Symrise earnings outlook in analyst focus, shares on Deutsche Börse radar
23.06.2026 - 11:10:11 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 11:08.
Symrise (DE000SYM9999) stands in the analyst spotlight on Xetra as investors look ahead to the next reporting dates. Recent research updates from UBS and JPMorgan confirm a constructive view on the flavor and fragrance specialist, with double-digit upside implied by their price targets.
What UBS and JPMorgan say
On 18 June 2026, UBS reiterated its Buy rating on Symrise and set a price target of 94 euros, pointing to solid growth in the core taste, nutrition and scent businesses according to a Dow Jones Newswires summary. The bank highlighted the group’s resilience in consumer staples relative to more cyclical chemical peers such as Givaudan and International Flavors & Fragrances.
Earlier in the month, JPMorgan confirmed an Overweight stance with a 100 euro target, citing structural demand for natural ingredients and Symrise’s diversified end-market mix as key supports, as reported in the same analyst round-up. This puts the company among the preferred names in the European specialty chemicals and ingredients complex for the US bank’s research team.
Consensus picture on the Symrise stock
MarketScreener data compiled around mid-June shows that a majority of covering analysts currently rate Symrise at Buy or equivalent, with a smaller group recommending Hold and only isolated Sell opinions. The average 12-month target price in that survey clusters in the low-to-mid 90-euro range, implying mid-teens percentage upside versus recent Xetra trading levels.
In a broader sector note on the fragrance and flavor industry from early June, Givaudan is described as the scale leader, but Symrise is highlighted as a strong challenger with competitive margins and robust exposure to food, pet nutrition and personal care applications. The note also underlines that ingredient suppliers like Symrise often show lower earnings volatility than commodity chemical producers listed in indices such as the DAX and Stoxx Europe 600.
All news and analysis on the Symrise shares
Further headlines, regulatory disclosures and historical price data on Symrise can be found in the dedicated topic overview and on the company’s Investor Relations pages.
How Symrise earns its money
Symrise generates its revenues mainly with flavorings, fragrances and functional ingredients that go into food and beverages, pet food, cosmetics and household products, according to its corporate profile. The company also sells specialty nutrition solutions, including ingredients for baby food, pharmaceuticals and probiotics, to brand manufacturers worldwide.
Where the shares trade today
The Symrise shares (DE000SYM9999) trade on Xetra on Deutsche Börse; the latest verifiable quotes show the stock changing hands in the low-80-euro range in June 2026, in line with its role as a mid-cap member of the German blue-chip universe.
Key data on the Symrise shares
- Company: Symrise AG
- ISIN: DE000SYM9999
- WKN: SYM999
- Ticker: SY1
- Trading venue: Xetra
- Price (as of 2026-06-23, 11:00): low-80s euros range
- Market cap: double-digit billion-euro range (as of 2026-06-23)
- Sector / industry: Specialty chemicals / flavors & fragrances
- Index membership: DAX / Stoxx Europe 600
- Next earnings date: not officially scheduled
This text is for informational purposes only and does not constitute investment advice, an offer or a solicitation to buy or sell any securities. Historical performance is not a reliable indicator of future results. Investors should conduct their own research and, where appropriate, seek professional advice.
